跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9,612 条关于
“NewAmsterdam Pharma”
全部
9,612
临床试验
4,079
药物
1,113
机构
1,219
资讯
3,201
去年
NewAmsterdam Pharma Advances Obicetrapib Program, Outlines 2025 Priorities
2年前
NewAmsterdam Pharma Announces 2024 Strategic Priorities and Clinical Trial Updates
去年
NewAmsterdam Pharma's Obicetrapib/Ezetimibe Combo Shows Promise in Phase 3 Trial
6小时前
Menarini Group and NewAmsterdam Pharma Win European Commission Approval for Obicetrapib
去年
Obicetrapib Shows Sustained LDL-C Reduction in HeFH Patients in Phase 3 Trial
去年
Obicetrapib Shows Promise in Phase 3 BROADWAY Trial, Reduces LDL-C and MACE
去年
NLS Pharmaceutics and NewAmsterdam Pharma File Mixed Securities Shelves Worth $75M and $500M Respectively
8个月前
NewAmsterdam Pharma Advances Obicetrapib Development with Promising Alzheimer's Biomarker Data and Multiple Phase 3 Trials
去年
NewAmsterdam Pharma's Obicetrapib-Ezetimibe Combo Achieves LDL-C Endpoint in Phase III Trial
去年
Rilzabrutinib and Obicetrapib Show Promise in Phase 3 Trials, Bolstering Buy Ratings
第 1 页,共 321 页
上一页
下一页